文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

炎症性肠病的遗传学与发病机制。

Genetics and pathogenesis of inflammatory bowel disease.

机构信息

Gastrointestinal Unit and Center for the Study of Inflammatory Bowel Disease, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA.

出版信息

Nature. 2011 Jun 15;474(7351):307-17. doi: 10.1038/nature10209.


DOI:10.1038/nature10209
PMID:21677747
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3204665/
Abstract

Recent advances have provided substantial insight into the maintenance of mucosal immunity and the pathogenesis of inflammatory bowel disease. Cellular programs responsible for intestinal homeostasis use diverse intracellular and intercellular networks to promote immune tolerance, inflammation or epithelial restitution. Complex interfaces integrate local host and microbial signals to activate appropriate effector programs selectively and even drive plasticity between these programs. In addition, genetic studies and mouse models have emphasized the role of genetic predispositions and how they affect interactions with microbial and environmental factors, leading to pro-colitogenic perturbations of the host-commensal relationship.

摘要

最近的进展为我们深入了解黏膜免疫的维持和炎症性肠病的发病机制提供了大量的信息。负责肠道内稳态的细胞程序利用多种细胞内和细胞间网络来促进免疫耐受、炎症或上皮修复。复杂的界面整合局部宿主和微生物信号,以有选择地激活适当的效应程序,甚至在这些程序之间驱动可塑性。此外,遗传研究和小鼠模型强调了遗传易感性的作用,以及它们如何影响与微生物和环境因素的相互作用,导致宿主共生关系的促结肠炎发生变化。

相似文献

[1]
Genetics and pathogenesis of inflammatory bowel disease.

Nature. 2011-6-15

[2]
Unravelling the pathogenesis of inflammatory bowel disease.

Nature. 2007-7-26

[3]
Immunopathophysiology of inflammatory bowel disease: how genetics link barrier dysfunction and innate immunity to inflammation.

Innate Immun. 2017-8

[4]
Intestinal microbiota in inflammatory bowel disease: friend of foe?

World J Gastroenterol. 2011-2-7

[5]
Molecular interactions between bacteria, the epithelium, and the mucosal immune system in the intestinal tract: implications for chronic inflammation.

Curr Issues Intest Microbiol. 2007-9

[6]
Intestinal homeostasis and its breakdown in inflammatory bowel disease.

Nature. 2011-6-15

[7]
Inflammatory bowel disease: is the intestine a Trojan horse?

Sci Prog. 2002

[8]
The interplay between microbes and the immune response in inflammatory bowel disease.

J Physiol. 2018-7-17

[9]
Commensal-innate immune miscommunication in IBD pathogenesis.

Dig Dis. 2012-7-12

[10]
Inflammatory bowel disease.

Annu Rev Immunol. 2010

引用本文的文献

[1]
Intestinal taurine acts as a novel immunometabolic modulator of IBD by degrading redundant mitochondrial RNA.

Cell Mol Immunol. 2025-9-8

[2]
Real-World Safety of Vedolizumab in Inflammatory Bowel Disease: A Retrospective Cohort Study Supported by FAERS Signal Analysis.

Pharmaceuticals (Basel). 2025-7-28

[3]
Autoimmune thyroid disease and pituitary adenoma in a female patient with 18p deletion syndrome: a case report and review of the literature.

BMC Endocr Disord. 2025-8-25

[4]
Mesenchymal stem cells in treating human diseases: molecular mechanisms and clinical studies.

Signal Transduct Target Ther. 2025-8-22

[5]
Sanren decoction ameliorates ulcerative colitis by modulating gut microbiota and macrophage polarization to enhance intestinal barrier function.

Chin Med. 2025-8-20

[6]
The role of multi-omics in biomarker discovery, diagnosis, prognosis, and therapeutic monitoring of tissue repair and regeneration processes.

J Orthop Translat. 2025-8-8

[7]
The intricate interactions between the lungs and gut in patients: unraveling the crosstalk mechanism.

Front Med (Lausanne). 2025-7-30

[8]
Effects of choline metabolite-trimethylamine N-oxide on immunometabolism in inflammatory bowel disease.

Front Immunol. 2025-7-17

[9]
The Impact of Genetic Variation on Drug Response in Adult IBD: A Systematic Review.

JGH Open. 2025-7-22

[10]
Effectiveness and safety of non-pharmacological therapies for the treatment of inflammatory bowel disease: a network meta-analysis.

Front Med (Lausanne). 2025-6-30

本文引用的文献

[1]
Foxp3(+) regulatory T cells promote T helper 17 cell development in vivo through regulation of interleukin-2.

Immunity. 2011-3-25

[2]
Three ulcerative colitis susceptibility loci are associated with primary sclerosing cholangitis and indicate a role for IL2, REL, and CARD9.

Hepatology. 2011-5-2

[3]
Cutting edge: Generation of colitogenic Th17 CD4 T cells is enhanced by IL-17+ γδ T cells.

J Immunol. 2011-3-14

[4]
Loss of intestinal core 1-derived O-glycans causes spontaneous colitis in mice.

J Clin Invest. 2011-3-7

[5]
NFIL3 is a regulator of IL-12 p40 in macrophages and mucosal immunity.

J Immunol. 2011-3-7

[6]
The transcription factors Blimp-1 and IRF4 jointly control the differentiation and function of effector regulatory T cells.

Nat Immunol. 2011-3-6

[7]
The IL23R R381Q gene variant protects against immune-mediated diseases by impairing IL-23-induced Th17 effector response in humans.

PLoS One. 2011-2-22

[8]
RORγt+ innate lymphoid cells regulate intestinal homeostasis by integrating negative signals from the symbiotic microbiota.

Nat Immunol. 2011-2-20

[9]
Control of the development of CD8αα+ intestinal intraepithelial lymphocytes by TGF-β.

Nat Immunol. 2011-2-6

[10]
Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47.

Nat Genet. 2011-2-6

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索